3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
30
Prostatic Neoplasms, Castration-Resistant
5
Neoplasm Metastasis
5
Breast Neoplasms
3
Prostate Carcinoma Metastatic to the Bone
2
Neoplasms
2
Hormone Refractory Prostate Cancer
2
Bone Metastatic Castration-resistant Prostate Cancer
2
Thyroid Neoplasms
1
Prostate Cancer Metastatic to Bone
1
Pain
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Lung Neoplasms
1
Fractures, Bone
1
Fatigue
1
Castration-resistant Prostate Cancer
1
Castrate-Resistant Prostate Cancer
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Bony Metastases From Castrate Refractory Prostate Cancer
1
Bone Neoplasms
1
Bone Metastases
1
Bone Diseases
1
Interventions
Fentanyl
19
Analgesia
15
Acupuncture Therapy
13
Oxycodone
12
Zoledronic Acid
11
Surveys and Questionnaires
10
nabiximols
9
Therapeutics
9
Morphine
9
Acetaminophen
9
Psychiatric Rehabilitation
8
Ketamine
8
Hydromorphone
7
Lidocaine
6
Ibandronic Acid
6
Radiotherapy
5
Early Intervention, Educational
5
Bupivacaine
5
Analgesics, Opioid
5
Yoga
4
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Ropivacaine
4
Music Therapy
4
Methadone
4
Massage
4
Aromatherapy
4
alvimopan
3
Tapentadol
3
Saline Solution
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Pain
×
radium Ra 223 dichloride
×
Clear all
NCT03223597
2022-04-15
ROTOR
The Netherlands Cancer Institute
Completed
300 enrolled